Weekly docetaxel in ormone refractory prostate cancer patients

被引：0
|
作者：
Lupo, G. [1 ]
Buemi, B. [1 ]
Marabello, G. [1 ]
Pettineo, G. [1 ]
Gnani, A. [1 ]
Caristi, N. [1 ]
Leone, A. [1 ]
Altavilla, G. [1 ]
机构：
[1] Univ Messina, Med Oncol & Innovat Therapies, I-98100 Messina, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII153 / VII153
页数：1
相关论文
共 50 条
  • [31] Ketoconazole retains activity in patients with docetaxel-refractory prostate cancer
    Galsky, M. D.
    Simon, K.
    Sonpavde, G.
    Hutson, T. E.
    Fleming, M.
    Kondagunta, G. V.
    Berry, W.
    ANNALS OF ONCOLOGY, 2009, 20 (05) : 965 - 966
  • [32] WEEKLY ADMINISTRATION OF PACLITAXEL IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS
    Lombardo, Laura
    Mucciarini, Claudia
    Castagnetti, Giovanni
    Nicolini, Massimiliano
    Maur, Michela
    Frassoldati, Antonio
    Conte, Pier Franco
    ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [33] 2-weekly versus 3-weekly docetaxel for prostate cancer
    Nanus, David M.
    Tagawa, Scott T.
    LANCET ONCOLOGY, 2013, 14 (02): : 98 - 99
  • [34] Weekly docetaxel and mitoxantrone prior to prostatectomy in patients with high risk localized prostate cancer
    Beer, TM
    Garzotto, M
    Lowe, BA
    Ellis, WJ
    Lange, PH
    Montalto, MA
    Higano, C
    JOURNAL OF UROLOGY, 2003, 169 (04): : 444 - 444
  • [35] Weekly docetaxel for advanced hormonerefractory prostate cancer-HRPC
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V.
    Leonardi, V.
    Laudani, A.
    Arcuri, C.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 76 - 76
  • [36] Phase II trial of weekly docetaxel and oral capecitabine in metastatic hormone-refractory prostate cancer.
    Marur, S.
    Heilbrun, L.
    Kucuk, O.
    Cher, M. L.
    Forman, J.
    Heath, E.
    Vaishampayan, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 250S - 250S
  • [37] Phase I/II study of weekly docetaxel and vinblastine in the treatment of hormone-refractory prostate cancer (HRPC).
    Ackler, JR
    Tester, WJ
    Leighton, JC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 771S - 771S
  • [38] Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy
    Ando, Takayuki
    Hosokawa, Ayumu
    Kajiura, Shinya
    Itaya, Yuko
    Ueda, Akira
    Fujinami, Haruka
    Nishikawa, Jun
    Kobayashi, Takashi
    Horikawa, Naoki
    Tsukioka, Yuji
    Yabushita, Kazuhisa
    Note, Masayuki
    Ogawa, Kohei
    Sugiyama, Toshiro
    GASTRIC CANCER, 2012, 15 (04) : 427 - 432
  • [39] Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy
    Takayuki Ando
    Ayumu Hosokawa
    Shinya Kajiura
    Yuko Itaya
    Akira Ueda
    Haruka Fujinami
    Jun Nishikawa
    Takashi Kobayashi
    Naoki Horikawa
    Yuji Tsukioka
    Kazuhisa Yabushita
    Masayuki Note
    Kohei Ogawa
    Toshiro Sugiyama
    Gastric Cancer, 2012, 15 : 427 - 432
  • [40] Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer
    Vordos, D
    Paule, B
    Vacherot, F
    Allory, Y
    Salomon, L
    Hoznek, A
    Yiou, R
    Chopin, D
    Abbou, CC
    de la Taille, A
    BJU INTERNATIONAL, 2004, 94 (04) : 524 - 527
12345